Autologous stem cell transplantation versus novel drugs or conventional … – Nature.com
|
Autologous stem cell transplantation versus novel drugs or conventional …
Nature.com High-dose therapy (HDT) followed by autologous stem cell transplantation (ASCT) is the most common first-line treatment for patients with multiple myeloma (MM) under 65 years of age. A second ASCT at first relapse is frequently used but is challenged … |
